Click here for printer friendly page

Nordic CapMan strengthens life sciences team

Nordic private equity firm, CapMan, has strengthened its life sciences investment team with the appointment of Yrjo Wichmann as investment director. Wichmann has over ten years experience in the Finnish life sciences sector.

Wichmann joins CapMan from FibroGen Europe where he served as chief financial officer. He previously worked in D Carnegie's Finland branch as a director in corporate finance, responsible for life sciences and healthcare sectors.

‘On their way to success, emerging Finnish life sciences companies need alternative funding sources and partners that can also provide and help them with contacts, management resources, business skills and operational advice,' said Wichmann.

‘I believe that CapMan, as a leading private equity investor in the Nordic area, is able to support emerging companies in a number of ways starting from its wide contact network and resource pool to solid operational and management systems. The expansion of CapMan's life sciences team to Finland is thus an exciting opportunity for the Finnish life science industry in general and me personally.'

CapMan is one of the leading private equity investors in the Nordic countries and specialises in mid-sized buy-outs in various industry sectors, including IT, telecommunications and life sciences. The firm currently manages approximately E1.65bn in total capital, of which E527m is managed by its affiliated company Access Capital Partners, a fund of funds that in European private equity funds.

Copyright © 2003 AltAssets